SCHEMBL20164757

SCHEMBL20164757

CNc1nc(NCCO)nc2c(NC)nc(Cl)nc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC29A1 Q99808 4/20 0.54
KMT2A Q03164 3/20 0.49
YTHDC1 Q96MU7 3/20 0.41
MEN1 O00255 1/20 0.41
GAA P10253 1/20 0.41
MAPK1 P28482 1/20 0.41
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA5A P35218 1/20 0.40
CA9 Q16790 1/20 0.40
CA14 Q9ULX7 1/20 0.40
CA5B Q9Y2D0 1/20 0.40
MAPT P10636 1/20 0.40
HTT P42858 1/20 0.40
ABCG2 Q9UNQ0 1/20 0.37
CDK1 P06493 2/20 0.36
IKBKB O14920 1/20 0.35
LMNA P02545 1/20 0.35
RECQL P46063 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20164431 0.88 SLC29A1 (0.46) SLC29A1KMT2AYTHDC1MAPK1MAPT
SCHEMBL30560031 0.85 KMT2A (0.49) SLC29A1KMT2AYTHDC1MEN1CA1
SCHEMBL16094346 0.85 KMT2A (0.49) SLC29A1KMT2AYTHDC1MEN1CA1
SCHEMBL20179388 0.83 SLC29A1 (0.66) SLC29A1KMT2AMEN1GAAMAPK1
Hydrochloric Acid SCHEMBL20164590 0.82 SLC29A1 (0.64) SLC29A1KMT2AMEN1GAAMAPK1
SCHEMBL20164763 0.80 SLC29A1 (0.60) SLC29A1KMT2AMEN1GAAMAPK1
SCHEMBL30560030 0.79 YTHDC1 (0.41) SLC29A1KMT2AYTHDC1MEN1CDK1
SCHEMBL30560033 0.79 YTHDC1 (0.41) SLC29A1KMT2AYTHDC1MEN1CDK1
SCHEMBL20164730 0.79 YTHDC1 (0.41) SLC29A1KMT2AYTHDC1MEN1CDK1
SCHEMBL20164777 0.79 SLC29A1 (0.53) SLC29A1KMT2AMEN1GAAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3316890-B1 NOVEL BREATHING CONTROL MODULATING COMPOUNDS, AND METHODS OF MAKING AND USING SAME NEURAD LTD (IL) 2023-09-06 EP disclosed
US-10294228-B2 Breathing control modulating compounds, and methods of making and using same NEURAD LTD. (IL) 2019-05-21 US disclosed
US-20180141953-A1 Novel Breathing Control Modulating Compounds, and Methods of Making and Using Same NEURAD LTD. (IL) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180141953-A1 Novel Breathing Control Modulating Compounds, and Methods of Making and Using Same MTNR1B, CHRM3, PER2 SLC29A1 4472/4885KMT2A 2456/4885YTHDC1 2024/4885
US-10294228-B2 Breathing control modulating compounds, and methods of making and using same MTNR1B, PDE3A, CHRM3 SLC29A1 4518/4885KMT2A 2528/4885YTHDC1 2085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.